Columbus Circle Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-89,132	Closed	-$5.59M	–	252
2016 Q1	$5.59M	Buy	89,132 +47,170	+112%	+$3.14M	0.05%	208
2015 Q4	$3.95M	Sell	41,962 -40,782	-49%	-$3.78M	0.03%	231
2015 Q3	$6.65M	Sell	82,744 -256,787	-76%	-$28.5M	0.06%	215
2015 Q2	$40.7M	Buy	339,531 +49,971	+17%	+$5.97M	0.29%	89
2015 Q1	$30.2M	Sell	289,560 -84,488	-23%	-$8.56M	0.21%	114
2014 Q4	$36.3M	Sell	374,048 -197,204	-35%	-$18.3M	0.26%	92
2014 Q3	$44.6M	Sell	571,252 -149,584	-21%	-$9.65M	0.32%	82
2014 Q2	$45.5M	Sell	720,836 -283,509	-28%	-$16.9M	0.31%	90
2014 Q1	$67.4M	Buy	1,004,345 +346,036	+53%	+$26.8M	0.45%	64
2013 Q4	$42.3M	Sell	658,309 -300,008	-31%	-$17.9M	0.29%	96
2013 Q3	$61.3M	Buy	958,317 +342,395	+56%	+$17.1M	0.43%	72
2013 Q2	$19.1M	Buy	+615,922	New	+$16.4M	0.15%	156